Marvel star Mark Ruffalo has said he's still keen for a solo Hulk movie — though isn't sure if it will ever happen. Ruffalo ...
Olsen last played Scarlet Witch in live-action form in 2022’s Doctor Strange in the Multiverse of Madness. She subsequently ...
Black Phone 2' star Madeleine McGraw, who played young Hope van Dyne in 'Ant-Man and the Wasp,' wants to play another Marvel ...
ThatDudeinBlue reveals his never-before-seen fight scene in *Hobbs and Shaw* and gives fans a behind-the-scenes look. Trump, Pulte Threats Fuel $19.5 Billion Homebuilders Rout Minnie Driver Slams Old ...
During an appearance Tuesday on the Tonight Show with Jimmy Fallon, WWE legend Dwayne "The Rock" Johnson described the legitimate physical pain he endured in a particular scene for the upcoming movie ...
SPOILER ALERT: This story contains spoilers from “Like a Keith in the Night,” Episode 7, Season 2 of “Peacemaker,” now streaming on HBO Max. After being fired from her high-level position at A.R.G.U.S ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. SAN DIEGO — Riding high on the success of its blockbuster weight loss drug, Eli ...
Two families whose children were among four University of Idaho students killed in a highly publicized attack in Moscow obtained a partial victory in their legal fight to prevent the release of crime ...
AbbVie stock (NYSE: ABBV) rallied 11% in a week, largely driven by a key development that boosted the entire sector: Pfizer’s agreement to lower its drug prices for Medicaid and a White House decision ...
Eric Dane has vowed to “fight to the last breath” amid his battle with ALS. The “Euphoria” actor, 52, opened up about his health diagnosis during a meeting with US Rep. Frank Pallone (D-NJ) in ...
Oct 7 (Reuters) - Peter Marks, the former top vaccine regulator who was ousted from the U.S. Food and Drug Administration earlier this year, has joined Eli Lilly (LLY.N), opens new tab, the drugmaker ...
Eli Lilly (NYSE:LLY) announced positive results from a late-stage trial of Omvoh (mirikizumab-mrkz) for patients suffering from moderately to severely active ulcerative colitis. The study demonstrated ...